20-Hydroxyeicosatetraenoic acid and epoxyeicosatrienoic acids and blood pressure
- 1 March 2001
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Nephrology and Hypertension
- Vol. 10 (2) , 231-237
- https://doi.org/10.1097/00041552-200103000-00012
Abstract
The properties of 20-hydroxyeicosatetraenoic acid and epoxyeicosatrienoic acids, vasoactivity and modulation of ion transport and mediation/modulation of the effects of vasoactive hormones, such as angiotensin II and endothelin, underscore their importance to renal vascular mechanisms and electrolyte excretion. 20-Hydroxyeicosatetraenoic acid is an integral component of renal autoregulation and tubuloglomerular feedback as well as cerebral autoregulation, eliciting vasoconstriction by the inhibition of potassium channels. Nitric oxide inhibits 20-hydroxyeicosatetraenoic acid formation, the removal of which contributes to the vasodilator effect of nitric oxide. In contrast, epoxyeicosatrienoic acids are generally vasodilatory by activating potassium channels and have been proposed as endothelium-derived hyperpolarizing factors. 20-Hydroxyeicosatetraenoic acid modulates ion transport in key nephron segments by influencing the activities of sodium-potassium-ATPase and the sodium-potassium-chloride co-transporter; however, the primacy of the various arachidonate oxygenases that generate products affecting these activities changes with age. The range and diversity of activity of 20-hydroxyeicosatetraenoic acid is influenced by its metabolism by cyclooxygenase to products affecting vasomotion and salt/water excretion. 20-Hydroxyeicosatetraenoic acid is the principal renal eicosanoid that interacts with several hormonal systems that are central to blood pressure regulation. This article reviews the most recent studies that address 20-hydroxyeicosatetraenoic acid and epoxyeicosatrienoic acids in vascular and renal tubular function and hypertension.Keywords
This publication has 31 references indexed in Scilit:
- Fenofibrate lowers blood pressure in two genetic models of hypertensionCanadian Journal of Physiology and Pharmacology, 2000
- Cytochrome P450 and Cyclooxygenase Metabolites Contribute to the Endothelin-1 Afferent Arteriolar Vasoconstrictor and Calcium ResponsesHypertension, 2000
- Inhibition of pressure natriuresis in mice lacking the AT2 receptorKidney International, 2000
- Renal cytochrome P450 ω-hydroxylase and epoxygenase activity are differentially modified by nitric oxide and sodium chlorideJournal of Clinical Investigation, 1999
- 20-Hydroxyeicosatetraenoic acid and renal function in Lyon hypertensive ratsEuropean Journal of Pharmacology, 1999
- Contribution of cytochrome P450 epoxygenase and hydroxylase pathways to afferent arteriolar autoregulatory responsivenessBritish Journal of Pharmacology, 1999
- Cloning of Trp1β isoform from rat brain: immunodetection and localization of the endogenous Trp1 proteinAmerican Journal of Physiology-Cell Physiology, 1999
- Functional response of the rat kidney to inhibition of nitric oxide synthesis: role of cytochrome P450‐derived arachidonate metabolitesBritish Journal of Pharmacology, 1998
- Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptorNature, 1995
- Treatment with Tin Prevents the Development of Hypertension in Spontaneously Hypertensive RatsScience, 1989